Trinity Biotech (TRIB) EBT Margin (2009 - 2024)
Trinity Biotech (TRIB) posted EBT Margin of 99.62% for Q4 2024, down 214.87% sequentially from 31.64% in Q3 2024, and down 5863.0% YoY from 1.73% in Q1 2024.
Trinity Biotech (TRIB) EBT Margin (2009 - 2024) Analysis & Trends
Trinity Biotech has reported EBT Margin for 16 years, with the latest figure at 99.62% in Q4 2024.
- Quarterly EBT Margin fell 5863.0% year-over-year to 99.62% in Q4 2024, while the trailing twelve-month figure through Dec 2024 was 49.92% (up 1506.0% YoY) and the FY2025 annual result came in at 84.91%, down 3499.0% from the prior year.
- EBT Margin fell to 99.62% in Q4 2024 per TRIB's latest filing, from 31.64% in the prior quarter.
- Over five years, EBT Margin peaked at 24.59% in Q3 2020 and troughed at 133.93% in Q2 2023.
- A 5-year average of 36.09% and a median of 41.79% in 2023 frame the typical range for EBT Margin.
- The sharpest annual moves came in 2020 and 2022: EBT Margin surged 9961 bps in 2020, then sank 10110 bps in 2022.
- Over 5 years, EBT Margin stood at 43.59% in 2020, then soared by 71 bps to 12.44% in 2021, then tumbled by 433 bps to 66.32% in 2022, then soared by 38 bps to 41.0% in 2023, then slumped by 143 bps to 99.62% in 2024.
- According to Business Quant data, EBT Margin over the past three periods registered 99.62%, 31.64%, and 43.48% for Q4 2024, Q3 2024, and Q2 2024 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.61 Bn | 194.01 Bn | 7.27 Bn | 12.10% |
| 2 | Stryker | 127.81 Bn | 124.34 Bn | 4.50 Bn | 23.74% |
| 3 | Medtronic | 119.04 Bn | 109.82 Bn | 6.41 Bn | 18.70% |
| 4 | Boston Scientific | 73.68 Bn | 73.14 Bn | 3.85 Bn | 19.48% |
| 5 | Edwards Lifesciences | 51.96 Bn | 47.71 Bn | 1.35 Bn | 29.86% |
| 6 | Dexcom | 34.36 Bn | 32.41 Bn | 830.00 Mn | 24.27% |
| 7 | GE HealthCare Technologies | 33.83 Bn | 31.72 Bn | 2.18 Bn | 13.09% |
| 8 | Koninklijke Philips | 26.36 Bn | 23.04 Bn | 4.55 Bn | 8.91% |
| 9 | Steris | 23.06 Bn | 22.58 Bn | 684.20 Mn | 18.32% |
| 10 | Trinity Biotech | 6.45 Mn | 1.31 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | -99.62% |
| Sep 30, 2024 | -31.64% |
| Jun 30, 2024 | -43.48% |
| Mar 31, 2024 | -22.10% |
| Dec 31, 2023 | -41.00% |
| Sep 30, 2023 | -44.27% |
| Jun 30, 2023 | -133.93% |
| Mar 31, 2023 | -42.59% |
| Dec 31, 2022 | -66.32% |
| Sep 30, 2022 | -63.59% |
| Jun 30, 2022 | -65.84% |
| Mar 31, 2022 | -84.34% |
| Dec 31, 2021 | -12.44% |
| Sep 30, 2021 | 7.28% |
| Jun 30, 2021 | -0.50% |
| Mar 31, 2021 | 16.76% |
| Dec 31, 2020 | -43.59% |
| Sep 30, 2020 | 24.59% |
| Jun 30, 2020 | 10.76% |
| Mar 31, 2020 | 13.96% |